The role of SMARCB1/INI1 in development of rhabdoid tumor

被引:152
作者
Roberts, Charles W. M. [3 ]
Biegel, Jaclyn A. [1 ,2 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Harvard Univ, Childrens Hosp, Dept Pediat Oncol, Dana Farber Canc Inst,Sch Med,Div Hematol Oncol, Boston, MA 02115 USA
关键词
rhabdoid tumor; retroperitoneum; angiogenesis; surgery; chemotherapy; radiotherapy; targeted therapy; recurrence; metastasis; CHROMATIN-REMODELING COMPLEX; ATYPICAL TERATOID/RHABDOID TUMORS; STRAND BREAK REPAIR; CELL-CYCLE ARREST; DNA-DAMAGE; SUPPRESSOR GENE; HSNF5/INI1; GENE; IMMUNOHISTOCHEMICAL ANALYSIS; MOLECULAR CHARACTERIZATION; FAMILIAL SCHWANNOMATOSIS;
D O I
10.4161/cbt.8.5.8019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A note about nomenclature: The ortholog of the gene mutated in rhabdoid tumors was first studied in yeast where it was identified in a screen for mutants incapable of fermenting sucrose. It was thus given the name Sucrose Non-Fermenting gene number 5 (SNF5) and was subsequently found to be a member of the SWI/SNF chromatin remodeling complex. The human ortholog of the gene was identified in a screen for proteins capable of interacting with the integrase protein of the human immunodeficiency virus and was given the name INtegrase Interactor 1 (INI1). Investigators studying a mammalian version of the Swi/Snf complex felt that its function may have diverged somewhat from the yeast complex and thus proposed renaming the complex the Brg1/Brm Associated Factors complex, or BAF complex. The rhabdoid tumor gene was thus given the name BAF47 based upon its apparent molecular mass of 47 Kd. Most recently, the genetic nomenclature committee bestowed the name SMARCB1 for SWI/SNF related, Matrix associated, Actin dependent Regulator of Chromatin, subfamily B, member 1. Each of these names has been used extensively in the literature and we ourselves have referred to the gene as either SNF5 (CWMR) or INI1 (JAB). In an effort to simplify communication, we have chosen to use the official SMARCB1 nomenclature here.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 50 条
  • [41] Congenital Anomalies and Rhabdoid Tumor Associated with 22q11 Germline Deletion and Somatic Inactivation of the SMARCB1 Tumor Suppressor
    Toth, George
    Zraly, Claudia B.
    Thomson, Tricia L.
    Jones, Carolyn
    Lapetino, Shawn
    Muraskas, Jonathan
    Zhang, Jiwang
    Dingwall, Andrew K.
    GENES CHROMOSOMES & CANCER, 2011, 50 (06) : 379 - 388
  • [42] Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience
    Diana Bell
    Ehab Y. Hanna
    Abbas Agaimy
    Annikka Weissferdt
    Virchows Archiv, 2015, 467 : 649 - 656
  • [43] Detection of SMARCB1 Loss in Ascites Cells in the Diagnosis of an Abdominal Rhabdoid Tumor
    Kerl, Kornelius
    Oyen, Florian
    Leuschner, Ivo
    Schneppenheim, Reinhard
    Nagel, Inga
    Siebert, Reiner
    Groll, Andreas H.
    Hartmann, Wolfgang
    Barth, Peter Josef
    Bartelheim, Kerstin
    Seringer, Angela
    Wardelmann, Eva
    Fruehwald, Michael C.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (05) : 897 - 900
  • [44] INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication
    Dixit, Updesh
    Bhutoria, Savita
    Wu, Xuhong
    Qiu, Liming
    Spira, Menachem
    Mathew, Sheeba
    Harris, Richard
    Adams, Lucas J.
    Cahill, Sean
    Pathak, Rajiv
    Kumar, P. Rajesh
    Nguyen, Minh
    Acharya, Seetharama A.
    Brenowitz, Michael
    Almo, Steven C.
    Zou, Xiaoqin
    Steven, Alasdair C.
    Cowburn, David
    Girvin, Mark
    Kalpana, Ganjam, V
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [45] Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors
    Hulsebos, Theo J. M.
    Kenter, Susan
    Verhagen, Wim I. M.
    Baas, Frank
    Flucke, Uta
    Wesseling, Pieter
    ACTA NEUROPATHOLOGICA, 2014, 128 (03) : 439 - 448
  • [46] Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development
    Vitte, Jeremie
    Gao, Fuying
    Coppola, Giovanni
    Judkins, Alexander R.
    Giovannini, Marco
    NATURE COMMUNICATIONS, 2017, 8
  • [47] Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1 ... but choriocarcinoma? ...
    Ricci, Costantino
    Ambrosi, Francesca
    Franceschini, Tania
    Giunchi, Francesca
    Franchini, Eugenia
    Massari, Francesco
    Mollica, Veronica
    Bianchi, Federico Mineo
    Colecchia, Maurizio
    Acosta, Andres Martin
    Fiorentino, Michelangelo
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 241
  • [48] Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology
    Ramalingam, Preetha
    Croce, Sabrina
    McCluggage, W. Glenn
    HISTOPATHOLOGY, 2017, 70 (03) : 359 - 366
  • [49] Treatment for SMARCB1 (INI-1) deficient sinonasal tumor: a single-institution study
    Wang, Tian
    Wang, Jie
    Tang, Tianci
    Wang, Li
    Li, Yi
    Song, Xinmao
    NEOPLASMA, 2023, 70 (06) : 804 - 810
  • [50] Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
    Thomas, Christian
    Oehl-Huber, Kathrin
    Bens, Susanne
    Soschinski, Patrick
    Koch, Arend
    Nemes, Karolina
    Oyen, Florian
    Kordes, Uwe
    Kool, Marcel
    Fruehwald, Michael C.
    Hasselblatt, Martin
    Siebert, Reiner
    GENES CHROMOSOMES & CANCER, 2021, 60 (08) : 586 - 590